Acute musculoskeletal neck and back pain

Back and neck pain is widespread in the population. Preferably, patients of working age are sick, which leads to serious economic losses. The transition of pain from acute to chronic increases financial costs, so effective treatment of back pain is an important medical, social and economic problem. Musculoskeletal pain (MSP) prevails among all types of back pain. The source of the MSP can be various structures of the musculoskeletal system: bones, joints, muscles, fascia, tendons, ligaments, intervertebral discs. The provoking factors for the development of the MSP are static and dynamic overloads arising from physical work, long stay in a fixed posture, unprepared movements, hypothermia, vibrations. The leading diagnostic method for the MSP is a physical research of a patient which includes a detailed collection of complaints and anamnesis, inspection in statics and dynamics, carrying out global and special tests, neuroorthopedic and neurological research. In most cases, the analysis of the results obtained allows you to set a clinical diagnosis without appointing additional research methods. Two cases of acute MSP with different localization, clinical manifestations and flow are offered to the discussion. In the first case, the process was localized in the muscles of the law back. In the second patient, the muscular tonic syndrome developed in the muscles of the neck and shoulder belt and was supported by functional blockades of the vertebral motor segments. For the treatment of both patients, NSAID, muscle relaxant, glucocorticoid, as well as non-drug therapy methods were used. For local injection therapy, a drug group of glucocorticoids was used, having a sodium phosphate and betamethazone dipropionate as part of the sodium betamethasone. The combination of two betamethazone salts provides both the rapid and prolonged effect of the drug, which makes it reasonable to use it with acute musculoskeletal pain.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. https://doi.org/10.1016/S0140-6736(15)60692-4.

2. Manek N.J., MacGregor A.J. Epidemiology of back disorders: prevalence, risk factors, and prognosis. Curr Opin Rheumatol. 2005;17(2):134–140. https://doi.org/10.1097/01.bor.0000154215.08986.06.

3. Kotova O.V., Akarachkova E.S. Back pain: epidemiology, etiology, treatment. Consilium Medicum. 2017;19(2.3. Neurology and Rheumatology):43–47. (In Russ.) Available at: https://cyberleninka.ru/article/n/bol-v-spineepidemiologiya-etiologiya-lechenie.

4. Hoy D., Brooks P., Blyth F., Buchbinder R. The Epidemiology of low back pain. Best Pract Res Clin Rheumatol. 2010;24(6):769–781. https://doi.org/10.1016/j.berh.2010.10.002.

5. Hoy D.G., Protani M., De R. The epidemiology of neck pain. Best Pract Res Clin Rheumatol. 2010;24(6):783–792. https://doi.org/10.1016/j.berh.2011.01.019.

6. Dagenais S., Caro J., Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J. 2008;8(1):8–20. https://doi.org/10.1016/j.spinee.2007.10.005.

7. Wieser S., Horisberger B., Schmidhauser S., Eisenring C., Brügger U., Ruckstuhl A. et al. Cost of low back pain in Switzerland in 2005. Eur J Health Econ. 2011;12(5):455–467. https://doi.org/10.1007/s10198-010-0258-y.

8. Buchner M., Neubauer E., Zahlten-Hinguranage A., Schiltenwolf M. Age as a predicting factor in the therapy outcome of multidisciplinary treatment of patients with chronic low back pain-a prospective longitudinal clinical study in 405 patients. Clin Rheumatol. 2007;26(3):385–392. https://doi.org/10.1007/s10067-006-0368-1.

9. Koes B.W., van Tulder M., Lin C.W., Macedo L., McAuley J., Maher C. An updated overview of clinical guidelines for the management of nonspecific low back pain in primary care. Eur Spine J. 2010;19:2075–2094. https://doi.org/10.1007/s00586-010-1502-y.

10. Oliveira C.B., Maher C.G., Pinto R.Z., Traeger A.C., Lin C.C., Chenot J.F. et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791–2803. https://doi.org/10.1007/s00586-018-5673-2.

11. Bardin L.D., King P., Maher C.G. Diagnostic triage for low back pain: a practical approach for primary care. Med J Aust. 2017;206(6):268–273. https://doi.org/10.5694/mja16.00828.

12. Heuch I., Foss I.S. Acute low back usually resolves quickly but persistent low back pain often persists. J Physiother. 2013;59(2):127. https://doi.org/10.1016/S1836-9553(13)70166-8.

13. Parfenov V.A. Management of patients with chronic nonspecific lumbar pain. Meditsinskiy sovet = Medical Council. 2019;(1):40–45. (In Russ.) https://doi.org/10.21518/2079-701X-2019-1-40-45.

14. Barinov A.N., Makhinov K.A., Sergienko D.A. Acute back pain. Meditsinskiy sovet = Medical Council. 2016;(8):44–49. (In Russ.) https://doi.org/10.21518/2079-701X-2016-8-44-49.

15. Karateev A.E. Diseases of the bone-muscular system in the practice of 2102 doctors of different specialties: the structure of the pathology and the opinion of specialists on the effectiveness of nsaids (preliminary data of epidemiological research-2). Consilium Medicum. 2013;15(9):95–100. (In Russ.) Available at: https://elibrary.ru/item.asp?id=20734187.

16. Nasonov E.L., Yakhno N.N., Karateev A.E., Alekseeva L.I., Barinov A.N., Barulin A.E. et al. General principles of treatment for musculoskeletal pain: Interdisciplinary consensus. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2016;54(3):247–265 (In Russ.) Available at: https://rsp.mediar-press.net/rsp/article/view/2206.

17. Yakhno N.N. (ed.). Pain syndrome: pathophysiology, clinical picture, treatment. Clinical guidelines. 2nd ed. Moscow: IMA-press; 2014. 64 p. (In Russ.) Available at: https://elibrary.ru/item.asp?id=30574304.

18. Kotova O.V., Akarachkova E.S., Danilov A.B. Long-term treatment of pain syndromes. RMJ. 2015;(29):16–18. (In Russ.) Available at: https://rmj.ru/articles/bolevoy_sindrom/Voprosy_dlitelynoy_terapii_bolevyh_sindromov.

19. Vertkin A.L., Karateev A.E., Kukushkin M.L., Parfenov V.A., Yakhno N.N. Consensus on the management of patients with back pain for therapists and general practitioners of polyclinics. Moscow; 2017. 16 p. (In Russ.) Available at: https://rnmot.ru/public/uploads/RNMOT/clinical/2017/консенсус.pdf.

20. Barinov A.N., Makhinov K.A., Sergienko D.A. Back pain: new technologies and old prejudices. Farmateka. 2016;(7):14–21. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/32989.

21. Karateev A.E., Alekseeva L.I. Analgesic treatment, by using a systemic algorithm. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2015;9(2):37–50. https://doi.org/10.14412/1996-7012-2015-2-37-50.

22. Parfenov V.A., Golovacheva V.A. Diagnosis and treatment of acute low back pain. Terapevticheskii arkhiv = Therapeutic Archive. 2019;91(8):155–159. (In Russ.) https://doi.org/10.26442/00403660.2019.08.000315.

23. Novikov A.Yu., Tikhomirov A.Yu., Novikov Yu.O., Tikhomirov R.A. Сomplex rehabilitation of patients with low back pain. Meditsinskiy vestnik Bashkortostana = Medical Bulletin of Bashkortostan. 2019;14(4):84–87. (In Russ.) Available at: https://mvb-bsmu.ru/files/journals/4_2019.pdf.

24. Badokin V.V. Locomotor therapy with extended-release crystalline glucocorticoids. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2013;5(2):88–92. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2420.

25. Barinov A.N., Mozolevsky Y.V. Combination treatment for tunnel neuropathies of the lower extremities. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2013;5(4): 10–20. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2449.

26. Alekseeva I.V., Usufov A.M., Pecherey I.O., Alekseev A.V. Legal aspects of the use of interventional pain treat-ment in neurology. Rossiyskiy zhurnal boli = Russian Journal of Pain. 2019;18(2):38–45. (In Russ.) https://doi.org/10.25731/RASP.2019.02.19.

27. Kukushkin M.L. Acute Back Pain: Diagnosis and Treatment. Nervnyye bolezni = Nervous Diseases. 2019;(2):46–51. (In Russ.) https://doi.org/10.24411/2226-0757-2019-12104.

28. Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011;13(6):513–520. https://doi.org/10.1007/s11926-011-0206-6.

29. Edmonds S. Therapeutic targets for osteoarthritis. Maturitas. 2009;63(3):191–194. https://doi.org/10.1016/j.maturitas.2009.03.015.

30. Igarashi A., Kikuchi S., Konno S., Olmarker K. Inflammatory cytokines released from the facet joint tissue in degenerative lumbar spinal disorders. Spine. 2004;29(19):2091–2095. https://doi.org/10.1097/01.brs.0000141265.55411.30.

31. Genevay S., Finckh A., Payer M. et al. Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc. Spine. 2008;33(19):2041–2046. https://doi.org/10.1097/BRS.0b013e318183bb86.

32. Cuellar J.M., Golish S.R., Reuter M.W. et al. Cytokine evaluation in individuals with low back pain using discographic lavage. Spine. 2010;10(3):212–218. https://doi.org/10.1016/j.spinee.2009.12.007.

33. McCarberg B. H., Ruoff G.E., Tenzer-Iglesias P., Weil A.J. Diagnosis and treatment of lowback pain because of paraspinous muscle spasm: a physician roundtable. Pain Med. 2011;12(4 Suppl.):119–127. https://doi.org/10.1111/j.1526-4637.2011.01253.x.

34. Lund J.P., Donga R., Widmer C.G., Stohler C.S. The pain-adaptation model: a discussion of the relationship between chronic musculoskeletal pain and motor activity. Can J Physiol Pharmacol. 1991;69:683–694. https://doi.org/10.1139/y91-102.

35. Roland M. A critical review of the evidence for pain-spasm-pain cycle in spinal disorders. Clin Biomech. 1986;1(2):102–109. https://doi.org/10.1016/0268-0033(86)90085-9.

36. Pogozheva E.Yu., Amirdzhanova V.N., Karateev A.E. Effective therapy of acute musculoskeletal pain: dexketoprofen. Consilium Medicum. Nevrologiya i revmatologiya = Consilium Medicum. Nevrology and Revmatology. 2018;(1):58–61. (In Russ.) Available at: https://elibrary.ru/item.asp?id=35407636.

37. Yakhno N.N., Barinov A.N., Podchufarova E.V. Neuropathic and musculoskeletal pain. Current approaches to diagnosis and treatment. Klinicheskaya meditsina = Clinical Medicine. 2008;86(11):9–15. (In Russ.) Available at: https://elibrary.ru/item.asp?id=12142133.

38. Blondell R.D., Azadfard M., Wisniewski A.M. Pharmacologic therapy for acute pain. Am Fam Physician. 2013;87(11):766–772. Available at: https://pubmed.ncbi.nlm.nih.gov/23939498.

39. Kroenke K., Krebs E.E., Bair M.J. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009;31(3):206–219. https://doi.org/10.1016/j.genhosppsych.2008.12.006.

40. Iskra D.A. Back pain: from correct diagnosis to pathogenetic therapy. Spravochnik poliklinicheskogo vracha = Outpatient Doctor’s Reference Book. (In Russ.) 2017;(5):58–62 Available at: https://omnidoctor.ru/library/izdaniya-dlya-vrachey/spravochnik-poliklinicheskogo-vracha/spv2017/spv2017_5/bol-v-spine-ot-korrektnoy-diagnostiki-k-patogeneticheskoyterapii.

41. Manchikanti L., Nampiaparampil D.E., Manchikanti K.N., Falco F.J., Singh V., Benyamin R.M. et al. Comparison of the efficacy of saline, local anesthetics, and steroids in epidural and facet joint injections for the management of spinal pain: A systematic review of randomized controlled trials. Surg Neurol Int. 2015;6(4 Supp.):194–235. https://doi.org/10.4103/2152-7806.156598.

42. Sklyarenko О.V., Sorokovikov V.A., Koshkareva Z.V., Zhivotenko A.P., Damdinov B.B. Conservative Treatment of Cervicobrachial Syndrome in Patients with Cervical Osteochondrosis (Literature Review). Acta Biomedica Scientifica. 2019;4(6):32–39. https://doi.org/10.29413/ABS.2019-4.6.5.

43. Andreev V.V., Barantsevich E.R., Sychev A.I. Effectiveness of local injective therapy use for lumbosacral pain syndromes. Uchenyye zapiski SPbGMU im. akad. I.P. Pavlova = The Scientific Notes of the Pavlov University. 2019;26(3):70–77. (In Russ.) https://doi.org/10.24884/1607-4181-2019-26-3-70-77.

44. Byröd G., Otani K., Brisby H., Rydevik B., Olmarker K. Methylprednisolone reduces the early vascular permeability increase in spinal nerve roots induced by epidural nucleus pulposus application. J Orthop Res. 2000;18(6):983–987. https://doi.org/10.1002/jor.1100180619.

45. Lundin A., Magnuson A., Axelsson K., Nilsson O., Samuelsson L. Corticosteroids peroperatively diminishes damage to the C-fibers in microscopic lumbar disc surgery. Spine. 2005;30(21):2362–2367. https://doi.org/10.1097/01.brs.0000184685.93424.f0.

46. Koshkarev M.A., Ivolgin A.F., Fokin N.Yu., Dyskin D.E. Рain as an interdisciplinary problem — current approaches to comprehensive treatment with local injection therapy. Gospitalnaya meditsina: nauka i praktika = Hospital Medicine: Science and Practice. 2019;1(1):26–31. (In Russ.) Available at: https://3hospital.ru/media/newspapers/gospmed_2019_01_01.pdf.

47. Pizova N.V., Lavrukhin V.V., Noskov S.M. Local glucocorticoid therapy or low back pain. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):48–51. (In Russ.) https://doi.org/10.14412/2074-2711-2010-116.

48. Plaue R., Hinz P. Gelenkinfektionen nach intraartikulärer Corticosteroidtherapie. Arch Orthop Unfallchir. 1969;67(2):101–113. https://doi.org/10.1007/BF00416831.

49. Chen M.Y., Tang Y.J., Wang Y.C., Wang C.Z., Yuan C.S., Chen Y. et al. Quantitative determination of betamethasone sodium phosphate and betamethasone dipropionate in human plasma by UPLC-MS/MS and a bioequivalence study. Anal Methods. 2016;8(17):3550–3563. https://doi.org/10.1039/C6AY00202A.